ED
OMC icon

Exane Derivatives’s Omnicom Group OMC Stock Holding History

Exane Derivatives’s Portfolio OMC Stock Details OMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$63.3K Buy
996
+95
+11% +$7.03K 0.04% 299
2022
Q1 		$76.5K Sell
901
-101
-10% -$8.12K 0.02% 509
2021
Q4 		$73.4K Buy
1,002
+985
+5,794% +$70.1K 0.02% 464
2021
Q3 		$1.23K Sell
17
-7,694
-100% -$572K ﹤0.01% 838
2021
Q2 		$601K Sell
7,711
-6,993
-48% -$568K 0.14% 149
2021
Q1 		$1.09M Buy
14,704
+5,829
+66% +$402K 0.31% 75
2020
Q4 		$554K Sell
8,875
-10,088
-53% -$577K 0.16% 136
2020
Q3 		$939K Sell
18,963
-17,009
-47% -$911K 0.27% 93
2020
Q2 		$1.96M Sell
35,972
-6,760
-16% -$368K 0.52% 55
2020
Q1 		$2.35M Sell
42,732
-828
-2% -$58.8K 0.66% 35
2019
Q4 		$3.46M Sell
43,560
-7,610
-15% -$596K 0.64% 54
2019
Q3 		$4.01M Sell
51,170
-1,195
-2% -$94.9K 0.72% 27
2019
Q2 		$4.29M Sell
52,365
-10,304
-16% -$813K 0.75% 26
2019
Q1 		$4.57M Buy
62,669
+1,341
+2% +$101K 0.9% 23
2018
Q4 		$4.49M Buy
61,328
+15,711
+34% +$1.17M 0.81% 23
2018
Q3 		$3.1M Buy
45,617
+14,001
+44% +$982K 0.58% 47
2018
Q2 		$2.41M Buy
31,616
+1,259
+4% +$93K 0.4% 48
2018
Q1 		$2.2M Buy
30,357
+20,155
+198% +$1.51M 0.44% 51
2017
Q4 		$743K Buy
10,202
+8,923
+698% +$640K 0.13% 137
2017
Q3 		$94.7K Buy
1,279
+1,244
+3,554% +$95.9K 0.02% 269
2017
Q2 		$2.9K Sell
35
-5
-13% -$417 ﹤0.01% 439
2017
Q1 		$3.45K Buy
40
+1
+3% +$85 ﹤0.01% 384
2016
Q4 		$3.32K Sell
39
-1
-3% -$84 ﹤0.01% 443
2016
Q3 		$3.4K Sell
40
-146,966
-100% -$12.3M ﹤0.01% 455
2016
Q2 		$12M Sell
147,006
-25,534
-15% -$2.12M 1.98% 16
2016
Q1 		$14.4M Buy
172,540
+171,031
+11,334% +$12.9M 1.91% 16
2015
Q4 		$114K Hold
1,509
– – 0.02% 192
2015
Q3 		$99.4K Sell
1,509
-783
-34% -$54.9K 0.01% 230
2015
Q2 		$159K Buy
2,292
+700
+44% +$52.9K 0.02% 222
2015
Q1 		$124K Buy
+1,592
New +$122K 0.01% 255

Other funds holding OMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's OMC Position: Q2 2022 in Review

Exane Derivatives increased its Omnicom Group (OMC) stake by 11% in Q2 2022, buying an estimated $7.03K and bringing the position to 996 shares worth $63.3K. The position accounts for 0.04% of the portfolio, ranked #299.

Exane Derivatives first reported a position in OMC in Q1 2015 and has held it in 30 quarters since. The position peaked at $14.4M in Q1 2016. 773 funds tracked by Wall St. Rank hold OMC as of Q2 2022.

  • Exane Derivatives held 996 shares of Omnicom Group worth $63.3K as of Q2 2022.
  • Exane Derivatives bought 95 Omnicom Group shares in Q2 2022, an estimated $7.03K.
  • Omnicom Group made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #299 holding.
  • Exane Derivatives first reported a position in Omnicom Group in Q1 2015 and has held it in 30 quarters since.
  • Exane Derivatives's Omnicom Group position peaked at $14.4M in Q1 2016.
  • 773 funds tracked by Wall St. Rank held Omnicom Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.